IGF1R and Bloom syndrome: Accordingly, PREX1, an IGF1R signalling activator, has been shown to have a pro-inflammatory role after BLM treatment, and Prex1-deficient mice mirrored the pro-inflammatory profile shown by our IGF1R-deficient mice at D341.